Showing results filtered by:
20 Results
PDP for Small Molecule Anti-infectives
https://www.niaid.nih.gov/sites/default/files/small-molecule-pdp-revised.pdf
Last Reviewed: March 31, 2025
Effective writing is an important skill that will benefit a scientist throughout every stage of their career. Postdoctoral fellow Sivarchana Boada, Ph.D., highlights the key components of successful academic and professional writing from January’s three-part skill blitz series.
Published: January 31, 2023
NIAID requires your human subjects research plans to include women, minorities, and participants of all ages unless you can justify their exclusion.
Last Reviewed: January 24, 2022
CMCRC Radiobiology Textbook - Chapter Five
https://www.niaid.nih.gov/sites/default/files/cmcrc-radiobiology-textbook-chapter-five.pdf
Last Reviewed: August 6, 2024
NIAID Biodefense Research Agenda for CDC Category A Agents - 2006 Progress Report
https://www.niaid.nih.gov/sites/default/files/cata_2006.pdf
Last Reviewed: August 6, 2019
NIAID Biodefense Research Agenda for CDC Category A Agents - Progress Report August 2003
https://www.niaid.nih.gov/sites/default/files/category_a_progress_report.pdf
Last Reviewed: August 6, 2019
Food Allergy Summary for Patients, Families, and Caregivers
https://www.niaid.nih.gov/sites/default/files/faguidelinespatient.pdf
Last Reviewed: July 9, 2019
Resources for NIAID grantees about the first events that occur after applications go through peer review and are approved for funding.
Last Reviewed: December 18, 2019
Sample Application (K08): Al-Adra
https://www.niaid.nih.gov/sites/default/files/1-k08-ai155816-01a1-aladra-application-508.pdf
Last Reviewed: September 13, 2024
NIAID's Advisory Council is comprised of both experts in health and science, contributing technical expertise and an understanding of the needs of research communities of academia and industry, and lay members, who impart a perspective of people and communities affected by diseases in the NIAID research mission.
Published: September 18, 2024
DAIDS Emergency Unblinding Policy
https://www.niaid.nih.gov/sites/default/files/POL-A15-OPC-00600-DAIDS-Emergency-Unblinding-Policy-Final.pdf
Last Reviewed: October 14, 2022
Current proposal for SBML3 multi-component multi-state (Meier-Schellersheim)
https://www.niaid.nih.gov/sites/default/files/sbml-multi-spec102.pdf
Last Reviewed: April 21, 2015
Sample Application (R44): Yingru Liu
https://www.niaid.nih.gov/sites/default/files/R44-Liu-Application.pdf
Last Reviewed: November 25, 2022
Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020
https://www.niaid.nih.gov/sites/default/files/ORWH-Biennial-Report2019-20.pdf
Last Reviewed: March 8, 2022
Jordan Report 20th Anniversary: Accelerated Development of Vaccines 2002
https://www.niaid.nih.gov/sites/default/files/jordan20_2002.pdf
Last Reviewed: December 31, 2002
DAIDS Policy Public Comment: Emergency Unblinding Policy
https://www.niaid.nih.gov/sites/default/files/Emergency-Unblinding-Policy-Public-Comment-120718.pdf
Last Reviewed: December 7, 2018
This page explains how principal investigators using live vertebrate animals should adhere to NIH requirements, prepare applications, and manage grants.
Last Reviewed: November 21, 2024
A collection of sample grant applications and other resources provided by NIAID investigators.
Last Reviewed: November 6, 2024
NIH Consolidated Opening Statement Senate LHHS FY 2019 Hearing
https://www.niaid.nih.gov/sites/default/files/NIH-Consolidated-Opening-Statement-Senate-LHHS-FY-2019-Hearing.pdf
Last Reviewed: August 16, 2018
The 203 rd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, January 30, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:51 a.m. and
Last Reviewed: February 5, 2024